Page 27 - Crispr News Today

Chinese experts are currently tackling how to look after the first genetically modified humans in history.

Donald Trump tried to loosen security before the riot, a former aide testified.

What do infectious diseases, T-cells, tomatoes, heart failure, sickle cell anemia and sorghum harvests have in common?

The gene-editing technology has led to innovations in medicine, evolution and agriculture — and raised profound ethical questions about altering human DNA.

The prospect of erasing some disabilities and perceived deficiencies hovers at the margins of what people consider ethically acceptable.

A new generation of scientists is growing up with CRISPR technology. Here’s how some high school students learn to edit genes.

The first human trial of CRISPR gene-editing technology in the United States has all but cured 31 patients of SCD and 44 of TDT.

Therapeutic drug monitoring and genomics studies are among the tools that can help elucidate and circumvent bacterias ability to resist antibiotics.

CRISPR gene-editing trials for treating beta thalassaemia and sickle cell disease are being extended to include people under the age of 12 after positive results in older people

One infusion of an investigational gene editing therapy could eliminate red blood cell transfusions in beta-thalassemia and severe vaso-occlusive crises in sickle cell disease.